- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Medications that interact with direct-acting oral anticoagulant exposure ; volume:29 ; number:9 ; day:18 ; month:8 ; year:2021 ; pages:417-418 ; date:9.2021
Netherlands heart journal ; 29, Heft 9 (18.8.2021), 417-418, 9.2021
- Creator
-
Vries, T. A. C. de
Groot, J. R. de
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12471-021-01617-z
- URN
-
urn:nbn:de:101:1-2021111219204573652010
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vries, T. A. C. de
- Groot, J. R. de
- SpringerLink (Online service)
Other Objects (12)
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Direct-acting antivirals and visceral leishmaniasis: a case report
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Direct-acting antivirals and visceral leishmaniasis: a case report
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Direct-acting antivirals and visceral leishmaniasis: a case report
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis